Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPSAP50 is a pseudogene annotated in the human genome as related to the ribosomal protein SA (RPSA)[5]. Pseudogenes are DNA sequences similar to known genes but usually non-functional due to mutations or lack of regulatory elements[7]. This gene does not encode a protein and does not have the biological activities of its parent RPSA, which itself is multifunctional, serving roles in ribosomal function, laminin binding, cancer metastasis, and as a biomarker for metastasis[1][3]. However, RPSAP50, being a pseudogene, is not known to be involved in any cellular function, therapeutic targeting, or disease processes. There are no recorded pharmacological interactions, disease associations, or safety concerns for this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein SA pseudogene 50 (RPSAP50).